Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVelocity Comp Regulatory News (VEL)

Share Price Information for Velocity Comp (VEL)

Share Price is delayed by 15 minutes
Get Live Data
16.25    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.50 (3.125%)
Market Cap: £8.88m
VEL Live PriceLast checked at - London Stock Exchange

Intraday Velocity Comp Share Chart

TR-1 notification

25 Feb 2011 16:04

RNS Number : 9111B
Velti PLC
25 February 2011
 



 

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi

1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached: ii

Velti Plc

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

Yes

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

An event changing the breakdown of voting rights

Other (please specify):

3. Full name of person(s) subject to thenotification obligation: iii

Credit Agricole Cheuvreux International Ltd

4. Full name of shareholder(s)  (if different from 3.):iv

5. Date of the transaction and date onwhich the threshold is crossed orreached: v

23/02/11

6. Date on which issuer notified:

25/02/11

7. Threshold(s) that is/are crossed orreached: vi, vii

Less than 3%

 

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

 

NumberofShares

NumberofVotingRights

Numberof shares

Number of votingrights

% of voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

JE00B41PDC45

1,521,500

1,521,500

Less than 3%

Less than 3%

Less than 3%

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Expirationdate xiii

Exercise/Conversion Period xiv

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

% of votingrights

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financialinstrument

Exercise price

Expiration date xvii

Exercise/Conversion period xviii

Number of voting rights instrument refers to

 

% of voting rights xix, xx

 

 

 

Nominal

Delta

Total (A+B+C)

Number of voting rights

Percentage of voting rights

Less than 3%

Less than 3%

 

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi

SAS Rue La Boétie

Crédit Agricole SA

Calyon SA

Crédit Agricole Cheuvreux SA

Crédit Agricole Cheuvreux International Limited Less than 3%

 

Proxy Voting:

10. Name of the proxy holder:

11. Number of voting rights proxy holder will ceaseto hold:

12. Date on which proxy holder will cease to holdvoting rights:

13. Additional information:

14. Contact name:

Olanike Bola-Lateef

15. Contact telephone number:

0207 214 6519

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLBLGDDGGDBGBU
Date   Source Headline
26th May 20267:00 amRNSTrading Statement
6th May 20269:07 amRNSHolding(s) in Company
23rd Apr 20267:00 amRNSBoard Change
23rd Mar 20262:18 pmRNSGrant of Share Options to Directors/PDMRs
17th Mar 202611:11 amRNSResult of AGM
9th Feb 202612:15 pmRNSChange of Joint Broker
27th Jan 202612:42 pmRNSReplacement - Audited Final Results
27th Jan 20267:00 amRNSFinal Results to the 31 October 2025
13th Jan 20263:49 pmRNS-RNotice of Investor Presentation - Replacement
8th Jan 20267:00 amRNS-RNotice of Investor Presentation
27th Nov 202510:19 amRNSPDMR/Director shareholding
25th Nov 202511:18 amRNSGrant of Share Options to Directors/PDMRs
5th Nov 20257:00 amRNSTrading Update
8th Oct 20257:00 amRNSContract Renewal and Expansion
8th Jul 202510:43 amRNSExercise of Share Options and Issue of Equity
25th Jun 20257:00 amRNSUnaudited Half Year Results
29th May 20257:00 amRNS-RNotice of Investor Presentation
22nd May 20257:00 amRNSTrading Update & Notice of Results
14th May 20253:16 pmRNSExercise of Share Options and Issue of Equity
12th May 20257:00 amRNSRenewal of BAE Systems Contract
6th May 20254:53 pmRNSHolding(s) in Company
6th May 202510:41 amRNSHolding(s) in Company
29th Apr 20255:26 pmRNSExercise of Share Options and Issue of Equity
28th Apr 20254:37 pmRNSPublication of Annual Report and Accounts
28th Mar 20252:49 pmRNSExercise of Share Options and Issue of Equity
17th Mar 20251:51 pmRNSDirector/PDMR Shareholding
11th Mar 202512:15 pmRNSResult of AGM
5th Mar 202510:53 amRNSDirector/PDMR Shareholding
4th Feb 20257:00 amRNS-RAppointment of Chief Operations Officer
3rd Feb 20257:00 amRNSGrant of Share Options
29th Jan 20257:00 amRNSAudited Final Results to 31 October 2024
15th Jan 20257:00 amRNS-RNotice of Investor Presentation
24th Dec 20247:00 amRNSDirector/PDMR Shareholding
20th Dec 20243:26 pmRNSExercise of Share Options and Issue of Equity
12th Dec 20247:00 amRNSTrading Update & Notice of Results
4th Nov 20244:43 pmRNSDirector/PDMR Shareholding
1st Nov 20247:00 amRNSTotal Voting Rights
7th Oct 20247:00 amRNSDirector/PDMR Shareholding
26th Sep 20245:48 pmRNSExercise of Share Options and Issue of Equity
18th Sep 20247:00 amRNSTrading Update
17th Jul 202410:16 amRNSHolding(s) in Company
17th Jul 20247:00 amRNSGrant of Share Options
16th Jul 20247:00 amRNSDirector/PDMR Shareholding
9th Jul 20247:00 amRNSHalf-Year Results
22nd May 20247:00 amRNSTrading Update & Notice of Results
13th May 20245:12 pmRNSReplacement: Holding(s) in Company
13th May 20242:31 pmRNSHolding(s) in Company
2nd May 20247:00 amRNSChange of Nominated Adviser and Corporate Broker
8th Apr 20244:38 pmRNSDirector/PDMR Shareholding
8th Apr 20247:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.